http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Kim, Sungha,Chung, Seung Eun,Lee, Sanghun,Park, Jeonghwan,Choi, Sunmi,Kim, Sungchul Informa UK (Informa Healthcare) 2016 Amyotrophic lateral sclerosis and frontotemporal d Vol.17 No.3
<P>The purpose of this study was to explore the life experience related to complementary and alternative medicine (CAM) use among patients with amyotrophic lateral sclerosis (ALS). Data were collected though semi-structured interviews of nine patients with ALS and seven family members, who have used CAM. Audio recordings of the interviews were transcribed verbatim and checked for accuracy. The Giorgi's method of phenomenology was used for data analysis. Five constituents forming the units of meaning were: facing the limits of conventional medicine; getting to know CAM; recognizing the ineffectiveness of CAM; using CAM for symptomatic treatment; and seeking new CAM endlessly for complete cure. The study results provide an in-depth understanding of experience with CAM among patients with ALS and their family members. Healthcare providers must give accurate information about the efficacy of CAM as well as its safety and possible adverse effects and should offer patient-centred treatment through active communication throughout the process of diagnosis and treatment.</P>
Statin and clinical outcomes of primary prevention in individuals aged >75 years: The SCOPE-75 study
Kim, Kyu,Lee, Chan Joo,Shim, Chi-Young,Kim, Jung-Sun,Kim, Byeong-Keuk,Park, Sungha,Chang, Hyuk-Jae,Hong, Geu-Ru,Ko, Young-Guk,Kang, Seok-Min,Choi, Donghoon,Ha, Jong-Won,Hong, Myeong-Ki,Jang, Yangsoo,L Elsevier Scientific Publ. Co 2019 Atherosclerosis Vol.284 No.-
<P><B>Abstract</B></P> <P><B>Background and aims</B></P> <P>Limited data is available on the benefit of statin for primary prevention in the elderly. The aim of this study is to investigate whether statin for primary prevention is effective in lowering the cardiovascular risk and all-cause death in individuals aged >75 years.</P> <P><B>Methods</B></P> <P>This was a retrospective, propensity score-matched study and data were acquired between 2005 and 2016 in a tertiary university hospital. Of the 6414 patients screened, 1559 statin-naïve patients without a history of atherosclerotic cardiovascular disease before the index visit were included. After propensity score matching, 1278 patients (639 statin users, 639 statin non-users) were finally analyzed. Primary outcome variables included major adverse cardiovascular and cerebrovascular events (MACCE) and all-cause death. MACCE included cardiovascular death, nonfatal myocardial infarction, coronary revascularization, and nonfatal stroke or transient ischemic attack.</P> <P><B>Results</B></P> <P>At a median follow-up of 5.2 years, statin users had lower rates of MACCE (2.15 <I>vs.</I> 1.25 events/100 person-years; hazard ratio, 0.59; <I>p</I> = 0.005) and all-cause death (1.19 <I>vs.</I> 0.65 events/100 person-years; hazard ratio, 0.56; <I>p</I> = 0.02), as well as lower levels of low-density lipoprotein-cholesterol than did non-users. The Kaplan-Meier curves revealed lower event rates in statin users (hazard ratio: 0.59 for MACCE and 0.56 for all-cause death). The incidence of myocardial infarction and coronary revascularization were lower in statin users.</P> <P><B>Conclusions</B></P> <P>Statin therapy for primary prevention was clearly associated with lower risk of cardiovascular events and all-cause death in individuals aged >75 years. These results support more active statin use in this population.</P> <P><B>Highlights</B></P> <P> <UL> <LI> Effect of statins for primary prevention was analyzed in individuals aged >75 years. </LI> <LI> Statin was associated with lower cardiovascular risk and all-cause death. </LI> <LI> Rates of MI and coronary revascularization were lower in statin users. </LI> <LI> These results support a more active statin use in this population. </LI> </UL> </P> <P><B>Graphical abstract</B></P> <P>[DISPLAY OMISSION]</P>
Discrimination accuracy between real and sham press needles in the hands
Kim, Sungha,Lee, Sanghun,Choi, Sunmi,Park, Jeonghwan,Kim, Sungchul THE BRITISH MEDICAL ACUPUNCTURE SOCIETY 2015 ACUPUNCTURE IN MEDICINE Vol.33 No.4
<P><B>Objectives</B></P><P>To evaluate the blinding effectiveness of a modified blunt sham press needle on the basis of the ability of subjects to discriminate between real and sham acupuncture needles compared with their discrimination ability based on pure guessing, and to define differences between senses (touch and vision) in the rates of correctly identified needles.</P><P><B>Methods</B></P><P>Sixty-three healthy students and staff members were recruited through convenience sampling. First, real or sham acupuncture was randomly administered to the left LI4 point while subjects could not observe the needle tip. A real or sham needle tip was then shown to the subjects. Finally, a random combination of real or sham acupuncture needles were randomly administered to the left and right LI4 points, this time with the subjects observing the procedure. In all conditions the subjects gave their judgement as Yes or No in response to questions asking them to identify the needle type. The proportion of correct judgements (P(C)) was computed for the last part of the trial in left and right LI4 points, and the rates of correctly identified needles for each trial were obtained.</P><P><B>Results</B></P><P>The subjects’ accuracy of discrimination between the real and sham acupuncture needles in left and right LI4 points was not significantly different from that based on pure guess (P(C)=0.50 (chance level)), which indicates complete inability to discriminate between needles. The rates of correctly identified needles using touch, vision and a combination of both senses were not significantly different (p=0.807).</P><P><B>Conclusions</B></P><P>The findings from this study show that this sham acupuncture device successfully blinded subjects to real and sham press needles, suggesting that it is effective for subject blinding in studies on acupuncture using press needles, and facilitating evaluation of the effects of acupuncture in placebo-controlled trials using a rigorous scientific research methodology.</P>